These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 31573044
1. Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition. Zhang H, Lin Y, Ma Y, Zhang J, Wang C, Zhang H. Int J Mol Med; 2019 Dec; 44(6):2091-2102. PubMed ID: 31573044 [Abstract] [Full Text] [Related]
2. miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1. Zhao H, Wang Y, Zhang X, Guo Y, Wang X. Toxicol Appl Pharmacol; 2020 Jan 01; 386():114827. PubMed ID: 31734320 [Abstract] [Full Text] [Related]
3. H2S inhibits pulmonary arterial endothelial cell inflammation in rats with monocrotaline-induced pulmonary hypertension. Feng S, Chen S, Yu W, Zhang D, Zhang C, Tang C, Du J, Jin H. Lab Invest; 2017 Mar 01; 97(3):268-278. PubMed ID: 27941756 [Abstract] [Full Text] [Related]
6. Microfluidic fabrication of inhalable large porous microspheres loaded with H2S-releasing aspirin derivative for pulmonary arterial hypertension therapy. Zhang H, Hao LZ, Pan JA, Gao Q, Zhang JF, Kankala RK, Wang SB, Chen AZ, Zhang HL. J Control Release; 2021 Jan 10; 329():286-298. PubMed ID: 33279605 [Abstract] [Full Text] [Related]
8. The protective mechanism of sevoflurane in pulmonary arterial hypertension via downregulation of TRAF6. Wang G, Wang C, Zhu P, Tian J, Yang H. Toxicol Appl Pharmacol; 2024 Oct 10; 491():117065. PubMed ID: 39127353 [Abstract] [Full Text] [Related]
10. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling. Liu T, Zou XZ, Huang N, Ge XY, Yao MZ, Liu H, Zhang Z, Hu CP. Life Sci; 2019 Jun 15; 227():64-73. PubMed ID: 31004656 [Abstract] [Full Text] [Related]
11. Mechanistic investigation of wogonin in delaying the progression of endothelial mesenchymal transition by targeting the TGF-β1 pathway in pulmonary hypertension. Wang X, Cui L, Wang Y, Zeng Z, Wang H, Tian L, Guo J, Chen Y. Eur J Pharmacol; 2024 Sep 05; 978():176786. PubMed ID: 38942264 [Abstract] [Full Text] [Related]
12. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension. Kang K, Xiang J, Zhang X, Xie Y, Zhou M, Zeng L, Zhuang J, Kuang J, Lin Y, Hu B, Xiong Q, Yin Q, Su Q, Liao X, Wang J, Niu Y, Liu C, Tian J, Gou D. Cell Mol Biol Lett; 2024 May 13; 29(1):69. PubMed ID: 38741032 [Abstract] [Full Text] [Related]
13. Sulfur Dioxide Protects Against Collagen Accumulation in Pulmonary Artery in Association With Downregulation of the Transforming Growth Factor β1/Smad Pathway in Pulmonary Hypertensive Rats. Yu W, Liu D, Liang C, Ochs T, Chen S, Chen S, Du S, Tang C, Huang Y, Du J, Jin H. J Am Heart Assoc; 2016 Oct 17; 5(10):. PubMed ID: 27792648 [Abstract] [Full Text] [Related]
14. Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling. Chen YJ, Li HF, Zhao FR, Yu M, Pan SY, Sun WZ, Yin YY, Zhu TT. Int Immunopharmacol; 2024 May 10; 132():111946. PubMed ID: 38552292 [Abstract] [Full Text] [Related]
15. Protective effects of hydrogen sulfide on portal hypertensive vasculopathy in rabbits by activating AKT-NF-κB pathway. Wang C, Han J, Li DJ, Yang Z, Zhang L. J Huazhong Univ Sci Technolog Med Sci; 2017 Jun 10; 37(3):348-351. PubMed ID: 28585141 [Abstract] [Full Text] [Related]
16. Activation of Nrf2 Attenuates Pulmonary Vascular Remodeling via Inhibiting Endothelial-to-Mesenchymal Transition: an Insight from a Plant Polyphenol. Chen Y, Yuan T, Zhang H, Yan Y, Wang D, Fang L, Lu Y, Du G. Int J Biol Sci; 2017 Jun 10; 13(8):1067-1081. PubMed ID: 28924387 [Abstract] [Full Text] [Related]
17. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage. Wang XH, Wang F, You SJ, Cao YJ, Cao LD, Han Q, Liu CF, Hu LF. Cell Signal; 2013 Nov 10; 25(11):2255-62. PubMed ID: 23872072 [Abstract] [Full Text] [Related]
18. [Effects of hydrogen sulfide on vascular inflammation in pulmonary hypertension induced by high pulmonary blood flow: experiment with rats]. Jin HF, Liang C, Liang JM, Tang CS, DU JB. Zhonghua Yi Xue Za Zhi; 2008 Aug 19; 88(32):2235-9. PubMed ID: 19087668 [Abstract] [Full Text] [Related]
19. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a. Li F, Wang D, Wang H, Chen L, Sun X, Wan Y. Respir Res; 2021 Aug 31; 22(1):239. PubMed ID: 34465322 [Abstract] [Full Text] [Related]
20. The Increased Endogenous Sulfur Dioxide Acts as a Compensatory Mechanism for the Downregulated Endogenous Hydrogen Sulfide Pathway in the Endothelial Cell Inflammation. Zhang D, Wang X, Tian X, Zhang L, Yang G, Tao Y, Liang C, Li K, Yu X, Tang X, Tang C, Zhou J, Kong W, Du J, Huang Y, Jin H. Front Immunol; 2018 Aug 31; 9():882. PubMed ID: 29760703 [Abstract] [Full Text] [Related] Page: [Next] [New Search]